drugset / Trial / NCT00302523

Tacrolimus Treatment of Patients With Idiopathic Membranous Nephropathy

NCT00302523

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is: * To explore the potential role of tacrolimus in the treatment of membranous nephropathy. * To investigate the safety and tolerability of tacrolimus vs methylprednisolone plus cyclophosphamide.

Timeline

Start
2006-03
Primary completion
2008-12
Completion
2009-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tacrolimus Small molecule 0.1 mg/kg Oral